Beijing Lüzhu Biotechnology Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
Profit Before Tax
-182.00
-275.00
-843.00
-650.00
-195.00
Adjustment
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
46.00
-1.00
-2.00
2.00
1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-90.00
-203.00
-92.00
-30.00
-10.00
Cash Flow from Investing Activities
-54.00
102.00
-259.00
-486.00
11.00
Cash Flow from Financing Activities
16.00
302.00
394.00
555.00
-1.00
Net Cash Inflow / Outflow
-127.00
208.00
42.00
38.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
7.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Beijing Lüzhu Biotechnology Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-182.404398143726
-275.713786253496
93.00
33.84%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
46.5359715441309
-27.0784904665472
73.00
271.86%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-90.8969900601981
-268.774753661468
178.00
66.18%
Cash Flow from Investing Activities
-54.7489671511017
189.796636301921
-243.00
-128.85%
Cash Flow from Financing Activities
16.8629334224708
282.774251915885
-266.00
-94.04%
Net Cash Inflow / Outflow
-127.68362081253
209.80598731534
-336.00
-160.86%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.09940297629945
6.00985275900184
-5.00
-81.71%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 55.35% vs -119.76% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-90.90
-203.55
55.35%






